Regulation of FGF signaling in lacrimal gland development

NIH RePORTER · NIH · R01 · $405,000 · view on reporter.nih.gov ↗

Abstract

PROJECT SUMMARY The long term objective of this project is to investigate regulation of FGF signaling in lacrimal gland development, which has important implications for understanding the etiology of diseased lacrimal gland in human. The lacrimal gland develops through a branching morphogenesis process primarily driven by FGF. We have previously shown that the Ras-MAPK pathway is an important downstream target of FGF signaling in lacrimal gland morphogenesis. In this application, we will test the hypothesis that PLCγ is also a critical regulator of FGF signaling in lacrimal gland development. Using conditional mutant mice and cell culture models, we will study how FGF receptor recruits and activates PLCγ. We will also examine the crosstalk between PLCγ and Ras signaling in lacrimal gland development. Finally, we will test the hypothesis that PLCγ modulates the strength of FGF signaling by controlling endocytosis of FGF receptor. By investigating the regulation of FGF signaling in murine lacrimal gland, this project will contribute to medical research in treating human lacrimal gland deficiency and the dry eye disease.

Key facts

NIH application ID
9989862
Project number
5R01EY018868-11
Recipient
COLUMBIA UNIVERSITY HEALTH SCIENCES
Principal Investigator
Xin Zhang
Activity code
R01
Funding institute
NIH
Fiscal year
2020
Award amount
$405,000
Award type
5
Project period
2009-01-01 → 2024-07-31